How much does a box of Lenvatinib cost?

Lenvatinib is indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC). Lenvatinib combined with pembrolizumab is suitable for first-line treatment of adult patients with advanced renal cell carcinoma; combined with everolimus is suitable for adult patients with advanced renal cell carcinoma who have previously received one anti-angiogenic therapy.

Lenvatinib is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). Lenvatinib in combination with pembrolizumab is indicated for the treatment of patients with advanced endometrial cancer (EC) that is mismatch repair proficient (pMMR) or not microsatellite instability high (MSI-H), who in any case have disease progression after prior systemic therapy and are not candidates for therapeutic surgery or radiation therapy.

Lenvatinib The original drug has been launched in China and has entered the scope of Class B medical insurance. The price of 4mg*30 tablets per box may be more than 3,000 yuan. Lenvatinib original drug currently on the market overseas, specifications 4mg*30 capsules, may cost more than 1,000 yuan per box (the price may fluctuate due to exchange rates). Lenvatinib generic drugs are also produced and marketed overseas. Their drug ingredients are basically the same as those of the original drugs sold domestically and abroad, but the price is cheaper. For example, the price of 4 mg*30 pills per box produced by a Bangladesh pharmaceutical factory may be RMB 800, and the price of 10 mg*30 pills per box may be more than RMB 1,000 (the price may fluctuate due to exchange rates).